azelastine has been researched along with chlorpheniramine in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (14.29) | 18.7374 |
1990's | 4 (28.57) | 18.2507 |
2000's | 4 (28.57) | 29.6817 |
2010's | 3 (21.43) | 24.3611 |
2020's | 1 (7.14) | 2.80 |
Authors | Studies |
---|---|
Carrupt, PA; Jolliet, P; Morin, C; Morin, D; Pagliara, A; Rihoux, JP; Testa, B; Tillement, JP; Urien, S | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 2 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Browning, C; Buckley, JM; Clark, KL; Fechner, L; Gore, PM; Hancock, AP; Hodgson, ST; Holmes, DS; Kranz, M; Looker, BE; Morriss, KM; Parton, DL; Procopiou, PA; Russell, LJ; Slack, RJ; Sollis, SL; Vile, S; Watts, CJ | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Campbell, BH; Connell, JT; Diamond, L; Donnelly, A; Hamilton, LH; Hemsworth, GR; Perhach, JL; Rosenthal, RR; Weiler, JM | 1 |
Kai, H; Katayama, K; Katayama, S; Sakuma, Y; Tanaka, I; Tsunoda, H | 1 |
Benson, PM; Freitag, J; Meltzer, EO; Weiler, JM; Weiler, K; Widlitz, MD | 1 |
Berkebile, C; Friedman, BS; Metcalfe, DD; Santiago, ML | 1 |
Kelso, JM | 1 |
Asano, K; Furuta, A; Hirano, K; Shoji, N; Suzaki, H | 1 |
Baek, SY; Kim, HI; Kim, JH; Kim, YK; Shin, DW; Woo, IS | 1 |
4 trial(s) available for azelastine and chlorpheniramine
Article | Year |
---|---|
Multicenter, double-blind, multiple-dose, parallel-groups efficacy and safety trial of azelastine, chlorpheniramine, and placebo in the treatment of spring allergic rhinitis.
Topics: Adolescent; Adult; Chlorpheniramine; Circadian Rhythm; Clinical Trials as Topic; Dizziness; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Phthalazines; Placebos; Pyridazines; Rhinitis, Allergic, Seasonal; Seasons; Sleep Stages; Taste | 1988 |
A dose-ranging study of the efficacy and safety of azelastine nasal spray in the treatment of seasonal allergic rhinitis with an acute model.
Topics: Administration, Intranasal; Adolescent; Adult; Aged; Child; Chlorpheniramine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Histamine H1 Antagonists; Humans; Male; Middle Aged; Phthalazines; Rhinitis, Allergic, Seasonal | 1994 |
Comparison of azelastine and chlorpheniramine in the treatment of mastocytosis.
Topics: Adult; Aged; Chlorpheniramine; Double-Blind Method; Drug Administration Schedule; Female; Histamine; Histamine H1 Antagonists; Humans; Male; Mastocytosis; Middle Aged; Phthalazines; Skin Tests; Urticaria | 1993 |
Study protocol on azelastine.
Topics: Anti-Allergic Agents; Chlorpheniramine; Data Interpretation, Statistical; Double-Blind Method; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Histamine H1 Antagonists; Humans; Phthalazines; Research Design; Rhinitis, Allergic, Perennial; Sample Size; United States; United States Food and Drug Administration | 1997 |
10 other study(ies) available for azelastine and chlorpheniramine
Article | Year |
---|---|
Molecular properties and pharmacokinetic behavior of cetirizine, a zwitterionic H1-receptor antagonist.
Topics: Alkanes; Animals; Biological Transport; Blood Proteins; Brain; Cetirizine; Histamine H1 Antagonists; Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydroxyzine; Isomerism; Models, Molecular; Molecular Conformation; Octanols; Rats; Water | 1998 |
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.
Topics: Administration, Intranasal; Administration, Oral; Drug Discovery; Histamine H1 Antagonists; Histamine H3 Antagonists; Humans; Models, Molecular; Phthalazines; Protein Conformation; Receptors, Histamine H1; Receptors, Histamine H3; Rhinitis | 2011 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Effect of azelastine on the release and action of leukotriene C4 and D4.
Topics: Animals; Arachidonate 5-Lipoxygenase; Chlorpheniramine; Guinea Pigs; Ileum; In Vitro Techniques; Ketotifen; Lung; Phthalazines; Pyridazines; SRS-A | 1987 |
Effect of histamine H1 receptor antagonists on TARC/CCL17 and MDC/CCL22 production from CD14+ cells induced by antigenic stimulation in vitro.
Topics: Adult; Antigens, Plant; Cell Proliferation; Chemokine CCL17; Chemokine CCL22; Chlorpheniramine; Extracellular Signal-Regulated MAP Kinases; GATA1 Transcription Factor; Gene Expression; Histamine; Histamine H1 Antagonists; Humans; Ketotifen; Leukocytes, Mononuclear; Lipopolysaccharide Receptors; Macrophages; Male; Middle Aged; NF-kappa B; Phosphorylation; Phthalazines; Piperazines; Plant Proteins; Rhinitis, Allergic, Seasonal; Signal Transduction; Terfenadine; Tuberculin; Young Adult | 2011 |
Development and validation of a simultaneous analytical method for non-steroidal therapeutic compounds in cosmetics using liquid chromatography-tandem mass spectrometry.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Bufexamac; Chlorpheniramine; Chromatography, High Pressure Liquid; Clotrimazole; Cosmetics; Doxepin; Fusidic Acid; Ketotifen; ortho-Aminobenzoates; Phthalazines; Tacrolimus; Tandem Mass Spectrometry | 2021 |